Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Menveo vaccine for the prevention of invasive meningococcal disease

Invasive meningococcal disease is predominantly caused by serogroups A, B, C, Y and W-135 worldwide.



Go Top